Document Detail

Safety issues in the management of autoimmune hepatitis.
MedLine Citation:
PMID:  18462189     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Prednisone and azathioprine are effective in the treatment of autoimmune hepatitis, but diverse side effects can diminish their net benefit. OBJECTIVES: Describe the frequency and nature of these side effects and propose management strategies to minimize their impact. METHODS: Pertinent articles published from 1970 to 2007 were identified by Medline search and through a personal library. RESULTS: Medication is prematurely discontinued in 13% of patients mainly because of cosmetic changes, cytopenia, or osteopenia. Populations at high risk are the elderly, those with pre-existent co-morbidities, patients with near-zero thiopurine methyltransferase activity, individuals who are treatment-dependent, pregnant women, and asymptomatic patients who are over-treated. CONCLUSIONS: Proper patient selection, effective pre-treatment counseling, preemptive protective measures, realistic treatment objectives, and early identification of problematic patients can reduce complications. Individualized dosing schedules and the emergence of non-steroidal medications are realistic expectations.
Albert J Czaja
Related Documents :
15106239 - Hyperbaric oxygen therapy for chronic wounds.
15930229 - Primary operative versus nonoperative therapy for pediatric empyema: a meta-analysis.
8393509 - The treatment of inclusion body myositis: a retrospective review and a randomized, pros...
17670709 - Does use of aprotinin decrease the incidence of stroke and neurological complications i...
15495129 - Antifibrinolytic drugs for acute traumatic injury.
7984699 - Reduced mortality, the ultimate indicator of treatment efficacy. review and perspectives.
6792379 - Penicillin v for group a streptococcal pharyngotonsillitis. a randomized trial of seven...
4013599 - Long-term results after incisional hernia repair.
14516029 - Survival analysis of hips treated with flexion osteotomy for femoral head necrosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Expert opinion on drug safety     Volume:  7     ISSN:  1744-764X     ISO Abbreviation:  Expert Opin Drug Saf     Publication Date:  2008 May 
Date Detail:
Created Date:  2008-05-08     Completed Date:  2008-06-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101163027     Medline TA:  Expert Opin Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  319-33     Citation Subset:  IM    
Mayo Clinic and Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, 200 First Street SW, Rochester, Minnesota 55905, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Azathioprine* / administration & dosage,  adverse effects,  therapeutic use
Drug Therapy, Combination
Glucocorticoids* / administration & dosage,  adverse effects,  therapeutic use
Hepatitis, Autoimmune / drug therapy*
Immunosuppressive Agents* / administration & dosage,  therapeutic use
Patient Selection
Prednisone* / administration & dosage,  adverse effects,  therapeutic use
Reg. No./Substance:
0/Glucocorticoids; 0/Immunosuppressive Agents; 446-86-6/Azathioprine; 53-03-2/Prednisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant antic...
Next Document:  The presence of an ER exit signal determines the protein sorting upon ER exit in yeast.